No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Silvia de Sanjosé, Wim Quint, Laia Alemany et al. · The Lancet Oncology · 2010 · 2.7K citations

Medicine, Genetics, Oncology +16

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Jorma Paavonen, Paulo Naud, Jorge Salmerón et al. · The Lancet · 2009 · 1.7K citations

Medicine, Gynecology, Oncology +17

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

Elmar A. Joura, Anna R. Giuliano, Ole‐Erik Iversen et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

Medicine, Oncology, Preventive Medicine +16

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

Suzanne M. Garland, Marc Steben, Heather L. Sings et al. · The Journal of Infectious Diseases · 2009 · 531 citations · Full text

Medicine, Gynecology, Infectious Diseases +17

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

BMJ · 2010 · 414 citations · Full text

Medicine, Gynecology, Oncology +17